• Viromed received Turkey ÜTS registration for its ViroCAP cold plasma device, clearing a key hurdle to market and distribute it.
• Roughly 2,000 units of ViroCAP have already been ordered in Turkey, enabling deliveries to start with local partners.
• The update follows earlier delays tied to MDR certification for the Class IIa device, then Turkey’s registration process.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2390516_en) on August 28, 2026, and is solely responsible for the information contained therein.